AngioDynamics, Inc.’s ANGO investors have been experiencing some short-term losses from the stock of late.Shares of the Latham, NY-based medical technology company have plunged 13.8% in the past ...

Stock analysts at Zacks Research upped their Q2 2026 earnings estimates for shares of AngioDynamics in a research report ...

Shares of ANGO stock opened at $9.40 on Thursday. The company has a market capitalization of $380.38 million, a price-to-earnings ratio of -1.67 and a beta of 0.57. AngioDynamics, Inc. has a one ...

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 16 cents for third-quarter fiscal 2024, wider than the year-ago loss of 3 cents per share and the Zacks Consensus Estimate of a loss ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Financial Health for AngioDynamics is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets. Loading view data ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.